 Acorda Therapeutics, Inc. Nasdaq: ACOR convened its Special Meeting of Stockholders on July 31, 2020, and stockholders approved proposals to authorize the Companys Board of Directors to implement a reverse stock split, and to adjourn the meeting to provide stockholders with additional time to vote on Proposal One to approve an increase to the number of authorized shares of common stock. The Special Meeting will be reconvened on Friday, August 28, 2020 at 9:00 a.m. Eastern Time at the Companys principal executive office located at 420 Saw Mill River Road, Ardsley, NY 10502. The sole matter of business before the reconvened Special Meeting will be Proposal One. 